Search

Your search keyword '"Andrew J. Copas"' showing total 32 results

Search Constraints

Start Over You searched for: Author "Andrew J. Copas" Remove constraint Author: "Andrew J. Copas"
32 results on '"Andrew J. Copas"'

Search Results

1. Re-analysis of data from cluster randomised trials to explore the impact of model choice on estimates of odds ratios: study protocol

2. Methodology of Natsal-COVID Wave 2: A large, quasi-representative, longitudinal survey measuring the impact of COVID-19 on sexual and reproductive health in Britain [version 2; peer review: 3 approved]

3. Methodology of Natsal-COVID Wave 2: A large, quasi-representative, longitudinal survey measuring the impact of COVID-19 on sexual and reproductive health in Britain [version 1; peer review: 2 approved]

4. Human papillomavirus infection: protocol for a randomised controlled trial of imiquimod cream (5%) versus podophyllotoxin cream (0.15%), in combination with quadrivalent human papillomavirus or control vaccination in the treatment and prevention of recurrence of anogenital warts (HIPvac trial)

5. Superiority and non-inferiority: two sides of the same coin?

6. Combined models for pre- and post-treatment longitudinal biomarker data: an application to CD4 counts in HIV-patients

7. Estimands in cluster-randomized trials: choosing analyses that answer the right question

8. Initial impacts of the COVID-19 pandemic on sexual and reproductive health service use and unmet need in Britain: findings from a quasi-representative survey (Natsal-COVID)

9. Improving clinical trial interpretation with ACCEPT analyses

11. How did the COVID-19 pandemic affect access to condoms, chlamydia and HIV testing, and cervical cancer screening at a population level in Britain? (Natsal-COVID)

12. Recruitment and implementation challenges were common in stepped-wedge cluster randomized trials: Results from a methodological review

13. Impacts of COVID-19 on sexual behaviour in Britain: findings from a large, quasi-representative survey (Natsal-COVID)

14. Initial Impacts of COVID-19 on Sex Life and Relationship Quality in Steady Relationships in Britain: Findings From a Large, Quasi-Representative Survey (Natsal-COVID)

15. Ethnic variations in sexual behaviours and sexual health markers: findings from the third British National Survey of Sexual Attitudes and Lifestyles (Natsal-3)

16. Ethnic variations in sexual behaviours and sexual health markers: findings from the third British National Survey of Sexual Attitudes and Lifestyles (Natsal-3)

17. Estimating the Prevalence of Sexual Function Problems: The Impact of Morbidity Criteria

18. Re: Medicated Sex in Britain: Evidence from the Third National Survey of Sexual Attitudes and Lifestyles

19. Epidemiology of Mycoplasma genitalium in British men and women aged 16–44 years: evidence from the third National Survey of Sexual Attitudes and Lifestyles (Natsal-3)

20. Asking about Sex in General Health Surveys: Comparing the Methods and Findings of the 2010 Health Survey for England with Those of the Third National Survey of Sexual Attitudes and Lifestyles

21. Ethnic variations in sexual activity and contraceptive use: national cross-sectional survey

22. Examining the potential public health benefit of offering STI testing to men in amateur football clubs: evidence from cross-sectional surveys

23. Is chlamydia screening and testing in Britain reaching young adults at risk of infection? Findings from the third National Survey of Sexual Attitudes and Lifestyles (Natsal-3)

24. Nonprobability Web surveys to measure sexual behaviors and attitudes in the general population: a comparison with a probability sample interview survey

25. A Declining CD4 Count and Diagnosis of HIV-Associated Hodgkin Lymphoma: Do Prior Clinical Symptoms and Laboratory Abnormalities Aid Diagnosis?

26. Methodology of the third British National Survey of Sexual Attitudes and Lifestyles (Natsal-3)

27. First sexual partnerships--age differences and their significance: empirical evidence from the 2000 British National Survey of Sexual Attitudes and Lifestyles ('Natsal 2000')

28. Drug-resistant HIV-1 in the semen of men receiving antiretroviral therapy with acute sexually transmitted infections

29. Who has sex with whom? Characteristics of heterosexual partnerships reported in a national probability survey and implications for STI risk.

30. Methodology of Natsal-COVID Wave 1: a large, quasi-representative survey with qualitative follow-up measuring the impact of COVID-19 on sexual and reproductive health in Britain [version 2; peer review: 2 approved]

31. Testing approaches to sharing trial results with participants: The Show RESPECT cluster randomised, factorial, mixed methods trial.

32. Imiquimod versus podophyllotoxin, with and without human papillomavirus vaccine, for anogenital warts: the HIPvac factorial RCT

Catalog

Books, media, physical & digital resources